芥酸酰胺 | 3061-72-1

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 中文名称: 芥酸酰胺
• 英文名称: docos-13-enamide
• 英文别名: 13-Docosenamide；erucamide；Docos-13-enamid；(Z)-docos-13-enamide；13Docosenamide
• CAS: 3061-72-1
• 化学式: C₂₂H₄₃NO
• mdl: MFCD00882379
• 分子量: 337.59
• InChiKey: UAUDZVJPLUQNMU-UHFFFAOYSA-N

物化性质

• 沸点：
  474.2±14.0 °C(Predicted)
• 密度：
  0.874±0.06 g/cm3(Predicted)
• 物理描述：
  DryPowder; DryPowder, PelletsLargeCrystals; OtherSolid; PelletsLargeCrystals

计算性质

• 辛醇/水分配系数(LogP)：
  8.8
• 重原子数：
  24
• 可旋转键数：
  19
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.863
• 拓扑面积：
  43.1
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2924199090

反应信息

• 作为产物：
  描述：

  docos-13-enoic acid-anhydride 在 乙醚 、 氨 作用下， 生成 芥酸酰胺
  参考文献：
  名称：

  Reimer; Will, Chemische Berichte, 1886, vol. 19, p. 3326

  摘要：

  DOI：

文献信息

• RECYCLABLE CLEAN FRACTURING FLUID THICKENER, PREPARATION METHOD AND RECOVERY METHOD THEREOF, AND HIGH-TEMPERATURE RESISTANT CLEAN FRACTURING FLUID
  申请人：SOUTHWEST PETROLEUM UNIVERSITY

  公开号：US20200354310A1

  公开（公告）日：2020-11-12

  Disclosed are a recyclable clean fracturing fluid thickener, a preparation method and a recovery method thereof, and a high-temperature resistant clean fracturing fluid, which relate to the stimulation treatment of oil and gas fields. Diethanolamine and thionyl chloride are used as raw materials and reacted to obtain an intermediate, which is then reacted with an unsaturated fatty acid amidopropyl dimethylamine to produce the recyclable clean fracturing fluid thickener. The clean fracturing fluid can be used in the fracturing stimulation treatment of low and medium permeability reservoirs.

  揭示了一种可回收的清洁压裂液增稠剂，以及其制备方法和回收方法，以及一种耐高温的清洁压裂液，涉及油气田的刺激处理。乙二醇胺和氯化亚硫酰作为原料，反应得到一种中间体，然后与不饱和脂肪酸酰胺丙基二甲胺反应，制备可回收的清洁压裂液增稠剂。这种清洁压裂液可用于低中渗透率油藏的压裂刺激处理。
• Scavenger assisted combinatorial process for preparing libraries of amides, carbamates and sulfonamides
  申请人：ELI LILLY AND COMPANY

  公开号：EP0825164A2

  公开（公告）日：1998-02-25

  This invention relates to a novel solution phase process for the preparation of amide, carbamate, and sulfonamide combinatorial libraries. These libraries have utility for drug discovery and are used to form wellplate components of novel assay kits.

  这项发明涉及一种用于制备酰胺、碳酸酯和磺酰胺组合库的新型溶液相过程。这些库在药物发现中具有实用价值，并用于形成新型检测套件的微孔板组件。
• [EN] POLYMERIC HYPERBRANCHED CARRIER-LINKED PRODRUGS<br/>[FR] PROMÉDICAMENTS LIÉS À DES EXCIPIENTS POLYMÉRIQUES HYPERBRANCHÉS
  申请人：ASCENDIS PHARMA AS

  公开号：WO2013024048A1

  公开（公告）日：2013-02-21

  The present invention relates to water-soluble carrier-linked prodrugs of formula (I),wherein POL is a polymeric moiety,each Hyp is independently a hyperbranched moiety,each moiety SP is independently a spacer moiety, each L is independently a reversible prodrug linker moiety, m is 0 or 1, each n is independently an integer from 2 to 200 and each x is independently 0 or 1. It further relates to pharmaceutical compositions comprising said water- soluble carrier-linked prodrugs and methods of treatment.

  本发明涉及水溶性载体连接的前药，其化学式为（I），其中POL是聚合物基团，每个Hyp是独立的超支化基团，每个基团SP是独立的间隔基团，每个L是独立的可逆前药连接基团，m为0或1，每个n是独立的整数，范围从2到200，每个x是独立的0或1。此外，还涉及包含所述水溶性载体连接的前药的药物组合物和治疗方法。
• TIACUMICIN DERIVATIVES AND THEIR USE AS ANTIBIOTICS
  申请人：Universität Zürich

  公开号：EP3508492A1

  公开（公告）日：2019-07-10

  The invention relates to a compound according to formula (1) wherein R1 to R4 and X are independently from each other a small functional group and R5 is -OH, or -O-Ln-Rap-Rbq-Lt-Rar-Rbs-Re, -O-Ln-Rbq-Rd-Lt-Rbs-Re with L being an alkyl linker, Ra being carbonyl, carboxyl or carboxamide, Rb being a cyclic moiety, Rd being a polyether linker and Re being a small functional end group, fluorescent dye or antibiotic with the proviso that the compound is not fidaxomicin. Furthermore, the invention relates to the use of the compound in the treatment of disease and the use in treating infections and/or bacterial infections caused by drug resistant bacteria.

  该发明涉及一种符合以下式（1）的化合物，其中R1至R4和X彼此独立地是小的功能基团，R5是-OH，或者-O-Ln-Rap-Rbq-Lt-Rar-Rbs-Re，-O-Ln-Rbq-Rd-Lt-Rbs-Re，其中L是烷基连接物，Ra是酰基，羧基或羧酰胺，Rb是环状基团，Rd是聚醚连接物，Re是小的功能末端基团，荧光染料或抗生素，但该化合物不是fidaxomicin。此外，该发明涉及该化合物在治疗疾病中的应用，以及在治疗由耐药细菌引起的感染和/或细菌感染中的应用。
• [EN] HIGH-LOADING WATER-SOLUBLE CARRIER-LINKED PRODRUGS<br/>[FR] PROMÉDICAMENTS LIÉS À DES EXCIPIENTS HYDROSOLUBLES DE FORTE CHARGE
  申请人：ASCENDIS PHARMA AS

  公开号：WO2013024047A1

  公开（公告）日：2013-02-21

  The present invention relates to water-soluble carrier-linked prodrugs of formula (I), wherein B, A and Hyp form the carrier, B is a branching core, each A is independently a poly(ethylene glycol)-based polymeric chain, each Hyp is independently a branched moiety, each SP is independently a spacer moiety, each L is independently a reversible prodrug linker moiety, each D is independendly a biologically active moiety, each x is independently 0 or 1, each m is independently an integer of from 2 to 64, n is an integer from 3 to 32; or the pharmaceutically acceptable salt thereof. It further relates to pharmaceutical compositions comprising said water-soluble carrier-linked prodrugs, their use asmedicament or diagnostic, and methods of treatment.

  本发明涉及水溶性载体连接的前药，其化学式为(I)，其中B、A和Hyp形成载体，B是一个分支核心，每个A独立地是一条聚乙二醇基聚合链，每个Hyp独立地是一个分支基团，每个SP独立地是一个间隔基团，每个L独立地是一个可逆前药连接基团，每个D独立地是一个生物活性基团，每个x独立地为0或1，每个m独立地是从2到64的整数，n是从3到32的整数；或其药学上可接受的盐。进一步涉及包括所述水溶性载体连接的前药的药物组合物，其用作药物或诊断，以及治疗方法。